a month ago
SLDB
AnalystsGena WangGena Wang's Stock Forecasts
AnalystsGena Wang
Sectors:
Industries:
Analyst Ranking
Top 32%
#1455 out of 4560 analysts
Average Return
+0.73%
Win Rate
40%45 out of 112
Risk vs Reward
Poor
Good
Gena Wang's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Beam Therapeutics IncBEAM | +315.20% | $23.02 | $95.58 | 2020-03-01 - 2021-03-01 | Strong Buy |
Moderna IncMRNA | +260.41% | $59.10 | $213.00 | 2020-06-07 - 2021-06-08 | Strong Buy |
Biocryst Pharmaceuticals IncBCRX | +170.38% | $3.95 | $10.68 | 2020-05-04 - 2021-05-05 | Strong Buy |
Abeona Therapeutics IncABEO | +156.56% | $152.50 | $391.25 | 2017-01-05 - 2018-01-05 | Strong Buy |
Avexis IncAVXS | +127.64% | $93.30 | $212.39 | 2017-09-06 - 2018-04-12 | Strong Buy |
Gena Wang Analyst Color
Get additional color on Gena Wang's coverage of popular stocks
2 months ago
RGNX
2 months ago
SRPT
4 months ago
VRTX
6 months ago
LEGN
9 months ago
VRTX
a year ago
LEGN
a year ago
LEGN
Gena Wang's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
4d Molecular Therapeutics IncFDMT | 1 | Strong Buy | $45.00 | +81.38% | Initiates Coverage On | 10 days ago |
Kodiak Sciences IncKOD | 7 | Strong Sell | $3.00 | -9.91% | Maintains | 24 days ago |
Solid Biosciences IncSLDB | 4 | Strong Buy | $21.00 | +130.52% | Maintains | a month ago |
Regenxbio IncRGNX | 5 | Strong Buy | $55.00 | +245.91% | Maintains | 2 months ago |
Editas Medicine IncEDIT | 5 | Hold | $11.00 | +101.47% | Maintains | 2 months ago |
Sarepta Therapeutics IncSRPT | 5 | Strong Buy | $185.00 | +57.96% | Maintains | 2 months ago |
Beam Therapeutics IncBEAM | 6 | Hold | $42.00 | +78.95% | Maintains | 2 months ago |
Crispr Therapeutics AgCRSP | 10 | Hold | $80.00 | +41.82% | Maintains | 2 months ago |
Vertex Pharmaceuticals IncVRTX | 12 | Strong Buy | $472.00 | +16.57% | Maintains | 3 months ago |
Legend Biotech CorpLEGN | 6 | Strong Buy | $94.00 | +98.10% | Maintains | 3 months ago |
Biomarin Pharmaceutical IncBMRN | 3 | Strong Buy | $111.00 | +20.57% | Maintains | 6 months ago |
Ptc Therapeutics IncPTCT | 10 | Hold | $25.00 | -1.61% | Maintains | 6 months ago |
Sangamo Therapeutics IncSGMO | 2 | Strong Buy | $9.00 | +1,627.45% | Maintains | 8 months ago |
Intellia Therapeutics IncNTLA | 5 | Strong Buy | $90.00 | +318.02% | Maintains | 9 months ago |
Mirati Therapeutics IncMRTX | 6 | Strong Buy | $71.00 | +20.95% | Maintains | 9 months ago |
Vir Biotechnology IncVIR | 2 | Strong Buy | $41.00 | +404.31% | Maintains | 9 months ago |
Bluebird Bio IncBLUE | 7 | Strong Buy | $8.00 | +723.89% | Upgrades | a year ago |
Ionis Pharmaceuticals IncIONS | 5 | Hold | $37.00 | -11.57% | Maintains | a year ago |
Seagen IncSGEN | 3 | Hold | $228.00 | N/A | Maintains | a year ago |
Zymeworks IncZYME | 1 | Hold | $9.00 | N/A | Maintains | a year ago |
Arcturus Therapeutics Holdings IncARCT | 5 | Hold | $25.00 | N/A | Upgrades | a year ago |
Alnylam Pharmaceuticals IncALNY | 3 | Strong Buy | $236.00 | N/A | Maintains | a year ago |
Biocryst Pharmaceuticals IncBCRX | 7 | Hold | $14.00 | N/A | Maintains | 2 years ago |
Cellectis SaCLLS | 1 | Strong Buy | $7.00 | N/A | Maintains | 2 years ago |
Orchard Therapeutics PLCORTX | 2 | Strong Buy | $40.00 | N/A | Maintains | 2 years ago |
Meiragtx Holdings PLCMGTX | 1 | Strong Buy | $18.00 | N/A | Maintains | 2 years ago |
Avrobio IncAVRO | 3 | Strong Buy | $4.00 | N/A | Maintains | 2 years ago |
Decibel Therapeutics IncDBTX | 2 | Strong Buy | $7.00 | N/A | Maintains | 2 years ago |
Sigilon Therapeutics IncSGTX | 1 | Strong Buy | $91.00 | N/A | Maintains | 2 years ago |
Logicbio Therapeutics IncLOGC | 1 | Strong Buy | $8.00 | N/A | Maintains | 2 years ago |
Moderna IncMRNA | 3 | Strong Buy | $404.00 | N/A | Maintains | 2 years ago |
Axonics IncAXNX | 1 | Strong Buy | $79.00 | N/A | Maintains | 3 years ago |
Ultragenyx Pharmaceutical IncRARE | 5 | Strong Buy | $141.00 | N/A | Maintains | 3 years ago |
Aceragen IncACGN | 1 | Hold | $2.00 | N/A | Downgrades | 3 years ago |
Eidos Therapeutics IncEIDX | 1 | Strong Sell | $45.00 | N/A | Downgrades | 4 years ago |
Tesaro IncTSRO | 1 | Hold | $75.00 | N/A | Downgrades | 5 years ago |
Puma Biotechnology IncPBYI | 5 | Strong Sell | $29.00 | N/A | Downgrades | 5 years ago |
Spark Therapeutics IncONCE | 4 | Strong Buy | $77.00 | N/A | Maintains | 6 years ago |
Avexis IncAVXS | 3 | Hold | N/A | N/A | Downgrades | 6 years ago |
Juno Therapeutics IncJUNO | 2 | Hold | N/A | N/A | Downgrades | 6 years ago |
Cascadian Therapeutics IncCASC | 1 | Strong Sell | $4.00 | N/A | Initiates Coverage On | 7 years ago |
Abeona Therapeutics IncABEO | 1 | Strong Buy | $275.00 | N/A | Initiates Coverage On | 7 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.